ClinicalTrials.gov
public full text
Public Domain
Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder
The purpose of this study is to evaluate the effects of twice-daily oral buspirone on core features of autism in autistic children aged 2-6 years as measured by the change from baseline in the Autism Diagnostic Observation Schedule (ADOS) Composite Total scores compared to placebo at 6 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits#915048
- Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder.#455446
- Comprehensive Communication Intervention for Minimally Verbal Children With Autism#893740
- Effects of Muscle Energy Technique With and Without Stationary Cycling on Toe Walking With ASD#1127220
- Bias in Measurement of Autism Symptoms by Spoken Language Level and Non-verbal Mental Age in Minimally Verbal Children with Neurodevelopmental Disorders#328062
Record · ID 1086538
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive